First Trust Advisors
SRNE

First Trust Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

First Trust Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-282,917
Closed -$2.16M – 2634
2021
Q3 		$2.16M Buy
282,917
+214,194
+312% +$1.82M ﹤0.01% 1750
2021
Q2 		$666K Buy
+68,723
New +$547K ﹤0.01% 2179
2021
Q1 		– Sell
-177,086
Closed -$1.21M – 2481
2020
Q4 		$1.21M Buy
+177,086
New +$1.42M ﹤0.01% 1818

Other funds holding SRNE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return